Phase II Study of MEDI4736 Monotherapy or in Combinations With Tremelimumab in Metastatic Pancreatic Ductal Carcinoma
Clinical trial NCT02558894 · COMPLETED
Trial details
- NCT number
- NCT02558894
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-16
- Primary completion
- 2017-06-15
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.